ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Natco Pharma eyes launch of 8-10 new drugs in India yearly
"Our strategy remains intact as we invest prudently in our research, manufacturing plants and enriching of skill sets. We are on track on our goal to launch 8-10 new products every year across our pharma business segments in India."
Announcement as on 15 October 2020

Natco Pharma eyes launch of 8-10 new drugs yearly in Indian market
Natco Pharma aims to launch around 10 new products every year in the Indian market, the city-based drug maker said on Thursday
Announcement as on 15 October 2020

Natco Pharma aims to diversify product portfolio in domestic market
Informing shareholders, the drug maker said its oncology segment suffered in the last financial year due to pricing controls from the government, and its Hepatitis-C business continued to decline due to reduction in market size.
Announcement as on 21 September 2020

Buy Natco Pharma: target of Rs 954: ICICI Securities
ICICI Securities is bullish on Natco Pharma recommended buy rating on the stock with a target price of Rs 954 in its research report dated September 18, 2020.
Announcement as on 18 September 2020

Natco Pharma soars 17% as path to launch Revlimid generic clears
Natco Pharma would be the first company to launch Revlimid (lenalidomide) in March 2022 as Dr Reddy’s settlement clears the path for the company. Dr Reddy’s would launch sometime after it (we assume 6 months) and would have market share restrictions lo
Announcement as on 18 September 2020

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 874.72
  • 12Day Average: 893.73
  • 20Day Average: 904
  • 50Day Average: 919.84
  • 100Day Average: 994.05
  • 150Day Average: 964.23
  • 200Day Average: 943.75

524816 Indicators & signals

Indicator MACD (12,26,9)

888.9, 905.99, -13.33
Indicator MACD is in negative zone

Indicator ADX (14)

8.21, 17.09, 20.15
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 46
Indicator RSI is indicating buying momentum and stock might rise.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
26 Wed Aug 2026 863.45 858.40 to 880.60 -0.35% 0.65 times
25 Tue Aug 2026 866.45 865.25 to 889.95 -1.92% 0.5 times
24 Mon Aug 2026 883.45 876.90 to 892.40 0.11% 0.82 times
21 Fri Aug 2026 882.50 877.95 to 900.00 0.54% 0.7 times
20 Thu Aug 2026 877.75 875.30 to 894.30 -1.05% 0.65 times
19 Wed Aug 2026 887.05 883.10 to 916.60 -1.2% 0.28 times
18 Tue Aug 2026 897.80 889.70 to 900.10 0.91% 0.35 times
17 Mon Aug 2026 889.70 870.70 to 898.85 -1.41% 1.15 times
14 Fri Aug 2026 902.40 885.75 to 962.25 -5.23% 3.53 times
13 Thu Aug 2026 952.25 917.60 to 960.40 4.07% 1.56 times
12 Wed Aug 2026 915.00 906.00 to 922.00 0.89% 0.46 times
11 Tue Aug 2026 906.90 903.55 to 929.40 -0.5% 0.73 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top